These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9243718)

  • 1. Effects of C-terminal fragments of cholecystokinin on plasma insulin and glucagon concentrations in sheep.
    Mineo H; Kamita H; Muto H; Ito M; Hyun HS; Onaga T; Yanaihara N
    Res Vet Sci; 1997; 62(2):171-4. PubMed ID: 9243718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intravenous infusions of cholecystokinin-8 and pentagastrin on plasma concentrations of insulin and glucagon in sheep.
    Mineo H; Iwaki N; Onaga T; Kato S
    Res Vet Sci; 1994 May; 56(3):298-302. PubMed ID: 8073180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intravenous infusions of cholecystokinin (CCK)-8 on exocrine and endocrine pancreatic secretion in conscious sheep.
    Mineo H; Iwaki N; Kogishi K; Zabielski R; Onaga T; Kato S
    Comp Biochem Physiol A Physiol; 1995 May; 111(1):133-8. PubMed ID: 7537612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of proglumide on cholecystokinin-8-induced exocrine and endocrine pancreatic responses in conscious sheep.
    Mineo H; Iwaki N; Kogishi K; Onaga T; Kato S; Zabielski R
    Comp Biochem Physiol A Physiol; 1997 Nov; 118(3):759-64. PubMed ID: 9406447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cholecystokinin and glucagon-like peptide 1 on the secretion of pancreatic polypeptide in mice.
    Ahrén B; Gingerich RL; Havel PJ
    Regul Pept; 1995 Nov; 59(3):297-302. PubMed ID: 8577934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cholecystokinin (CCK)-4, nonsulfated CCK-8, and sulfated CCK-8 on pancreatic somatostatin, insulin, and glucagon secretion in the dog: studies in vitro.
    Hermansen K
    Endocrinology; 1984 May; 114(5):1770-5. PubMed ID: 6143659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of six cholecystokinin (CCK) fragments on insulin secretion in the mouse.
    Ahrén B; Hedner P; Lundquist I
    Acta Pharmacol Toxicol (Copenh); 1986 Feb; 58(2):115-20. PubMed ID: 3518338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man.
    Ahrén B; Pettersson M; Uvnäs-Moberg K; Gutniak M; Efendic S
    Diabetes Res Clin Pract; 1991 Sep; 13(3):153-61. PubMed ID: 1683622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous opioids modulate the effect of cholecystokinin on insulin release in dogs.
    Schusdziarra V; Lenz N; Rewes B; Pfeiffer EF
    Neuropeptides; 1984 Nov; 4(6):507-17. PubMed ID: 6096758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin (CCK)-33 stimulates insulin secretion from the perfused rat pancreas: studies on the structure-activity relationship.
    Sandberg E; Ahrén B; Tendler D; Efendic S
    Pharmacol Toxicol; 1988 Jul; 63(1):42-5. PubMed ID: 3041399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of C-terminal fragments of cholecystokinin on exocrine and endocrine secretion from isolated perfused rat pancreas.
    Okabayashi Y; Otsuki M; Ohki A; Sakamoto C; Baba S
    Endocrinology; 1983 Dec; 113(6):2210-15. PubMed ID: 6196184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic effect of oral cholestyramine, a bile salt sequestrant, and exogenous cholecystokinin on insulin release in rats.
    Kogire M; Gomez G; Uchida T; Ishizuka J; Greeley GH; Thompson JC
    Pancreas; 1992; 7(1):15-20. PubMed ID: 1557341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin and gastrin induce cell contraction in pig ileum by interacting with different receptor subtypes.
    Botella A; Delvaux M; Berry P; Frexinos J; Bueno L
    Gastroenterology; 1992 Mar; 102(3):779-86. PubMed ID: 1537515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action of cholecystokinin analogues on exocrine and endocrine rat pancreas.
    Otsuki M; Okabayashi Y; Ohki A; Oka T; Fujii M; Nakamura T; Sugiura N; Yanaihara N; Baba S
    Am J Physiol; 1986 Apr; 250(4 Pt 1):G405-11. PubMed ID: 2421584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
    Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
    Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
    Millington WR; Mueller GP; Lavigne GJ
    J Pharmacol Exp Ther; 1992 May; 261(2):454-61. PubMed ID: 1578360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCK-octapeptide injected into cerebral ventricles of sheep decreases plasma insulin level.
    Della-Fera MA; Baile CA
    Physiol Behav; 1985 Feb; 34(2):283-9. PubMed ID: 3889948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidiabetogenic action of cholecystokinin-8 in type 2 diabetes.
    Ahrén B; Holst JJ; Efendic S
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1043-8. PubMed ID: 10720037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cholecystokinin (CCK-33) and its fragments, C-terminal octapeptide (CCK-8) and C-terminal tetrapeptide (CCK-4), on the circulatory system of diabetic rats.
    Fiedorowicz RJ; Wiśniewski K
    Pol J Pharmacol Pharm; 1989; 41(6):561-72. PubMed ID: 2485904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin (CCK)-4 and CCK-8 stimulate islet hormone secretion in vivo in the pig.
    Ahrén B; Mårtensson H; Nobin A
    Pancreas; 1988; 3(3):279-84. PubMed ID: 2898779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.